Carregant...
P10.04 Anti-angiogenetic Therapy with Bevacizumab for Gliomas with a Gliomatosis Cerebri Growth Pattern
Anti-angiogenetic therapy is widely used in patients with glioma in the relapse situation. In glioblastoma and glioma, bevacizumab has been shown to have an impact on progression-free survival and neurologic function, but not on overall survival. However, its use on patients with gliomas showing a g...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463866/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.322 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|